These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12505280)

  • 41. Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds.
    Pereira EF; Aracava Y; DeTolla LJ; Beecham EJ; Basinger GW; Wakayama EJ; Albuquerque EX
    J Pharmacol Exp Ther; 2014 Aug; 350(2):313-21. PubMed ID: 24907067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics of the inhibitory interaction of organophosphorus neuropathy inducers and non-inducers in soluble esterases in the avian nervous system.
    Mangas I; Vilanova E; Estévez J
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):360-8. PubMed ID: 21600909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurological aspects of organophosphate poisoning.
    De Bleecker JL; De Reuck JL; Willems JL
    Clin Neurol Neurosurg; 1992; 94(2):93-103. PubMed ID: 1324821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Organophosphorus ester-induced delayed neurotoxicity.
    Abou-Donia MB
    Annu Rev Pharmacol Toxicol; 1981; 21():511-48. PubMed ID: 7016015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
    Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
    Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of oxidative stress in organophosphate and nerve agent toxicity.
    Pearson JN; Patel M
    Ann N Y Acad Sci; 2016 Aug; 1378(1):17-24. PubMed ID: 27371936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity.
    Kaur S; Singh S; Chahal KS; Prakash A
    Can J Physiol Pharmacol; 2014 Nov; 92(11):893-911. PubMed ID: 25348489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurobehavioural effects of pesticides with special focus on organophosphorus compounds: which is the real size of the problem?
    Colosio C; Tiramani M; Brambilla G; Colombi A; Moretto A
    Neurotoxicology; 2009 Nov; 30(6):1155-61. PubMed ID: 19751763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An uncommon pattern of polyneuropathy induced by lifetime exposures to drift containing organophosphate pesticides.
    Ophir A; Karakis I; Richter ED; Abarbanel JM; Wormser U; Aschner M; Finkelstein Y
    Neurotoxicology; 2014 Dec; 45():338-46. PubMed ID: 25128617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organophosphate-induced delayed neurotoxicity of triarylphosphates.
    Weiner ML; Jortner BS
    Neurotoxicology; 1999 Aug; 20(4):653-73. PubMed ID: 10499364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of SH-SY5Y human neuroblastoma cells in the cell cycle following exposure to organophosphorus compounds.
    Carlson K; Ehrich M
    J Biochem Mol Toxicol; 2008; 22(3):187-201. PubMed ID: 18561334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotoxic effects in patients poisoned with organophosphorus pesticides.
    Jokanović M; Kosanović M
    Environ Toxicol Pharmacol; 2010 May; 29(3):195-201. PubMed ID: 21787602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated exposure to neurotoxic levels of chlorpyrifos alters hippocampal expression of neurotrophins and neuropeptides.
    Lee YS; Lewis JA; Ippolito DL; Hussainzada N; Lein PJ; Jackson DA; Stallings JD
    Toxicology; 2016 Jan; 340():53-62. PubMed ID: 26775027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers.
    Pilkington A; Buchanan D; Jamal GA; Gillham R; Hansen S; Kidd M; Hurley JF; Soutar CA
    Occup Environ Med; 2001 Nov; 58(11):702-10. PubMed ID: 11600725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral cholinesterase inhibition by occupational chlorpyrifos exposure in Australian termiticide applicators.
    Dyer SM; Cattani M; Pisaniello DL; Williams FM; Edwards JW
    Toxicology; 2001 Dec; 169(3):177-85. PubMed ID: 11718958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene-environmental interactions and organophosphate toxicity.
    Povey AC
    Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlorpyrifos-induced delayed myelopathy and pure motor neuropathy: a case report.
    Thivakaran T; Gamage R; Gunarathne KS; Gooneratne IK
    Neurologist; 2012 Jul; 18(4):226-8. PubMed ID: 22735254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A murine model for sarin exposure using the carboxylesterase inhibitor CBDP.
    Garrett TL; Rapp CM; Grubbs RD; Schlager JJ; Lucot JB
    Neurotoxicology; 2010 Sep; 31(5):502-8. PubMed ID: 20510297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cytoskeleton as a non-cholinergic target of organophosphate compounds.
    Hernandez-Toledano D; Vega L
    Chem Biol Interact; 2021 Sep; 346():109578. PubMed ID: 34265256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of epidemiologic studies of low-level exposures to organophosphorus insecticides in non-occupational populations.
    Reiss R; Chang ET; Richardson RJ; Goodman M
    Crit Rev Toxicol; 2015; 45(7):531-641. PubMed ID: 26153436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.